Full-Time

Data Scientist

Workflow Automation

Flatiron Health

Flatiron Health

1,001-5,000 employees

Cancer-focused EHR platform for real-world data

No salary listed

New York, NY, USA

Hybrid

Three office days per week are required; remaining workdays are from home.

Bachelor's, Master's, PhD

Category
Data & Analytics (1)
Required Skills
LLM
Python
JavaScript
Airflow
Webhooks
Data Science
Data Engineering
Version Control
n8n
REST APIs
Data Analysis
OAuth
Zapier

Get referred to Flatiron Health

See people who can refer or advise you

Requirements
  • Have 1-3 years of relevant working experience as an applied data scientist or similar technical data-oriented professional.
  • Have prior experience with large language models.
  • Hold a bachelor's, master's, and/or Ph.D. in computer science, data science, or a related field.
  • Understand how artificial intelligence systems are evaluated, including analyzing output quality, identifying improvements, and communicating their impact to stakeholders.
  • Have curiosity and knowledge to investigate, discover, and evaluate new and emerging artificial intelligence architectures and designs.
  • Have collaborated with technical team members in a production development environment using formal version control, Python, or JavaScript.
  • Have experience parsing JSON, transforming payloads, and connecting to databases or third-party services through REST APIs.
  • Be able to communicate clearly and confidently and explain complex data analyses to stakeholders.
Responsibilities
  • Partner with stakeholders across teams to intake automation requests, define requirements, and align on priorities.
  • Design, build, test, and maintain automations using platforms such as n8n to connect systems and automate organizational processes.
  • Write design documents that scope technical approaches, surface tradeoffs, and set expectations with partners.
  • Write code for custom logic, data transformation, and application programming interface integrations.
  • Monitor production workflows, troubleshoot failures, and build error handling and alerting into workflows.
  • Document workflows so they can be understood, maintained, and extended by others.
Desired Qualifications
  • Familiarity with workflow automation platforms such as n8n, Zapier, Make, or Airflow.
  • Deeper understanding of application programming interfaces, including REST, webhooks, and authentication patterns such as OAuth and API keys.
  • Background in consulting, data analysis, solutions engineering, data engineering, or a similar hybrid technical/product role.

Flatiron Health focuses on cancer care with a specialized Electronic Health Record (EHR) platform. It helps community oncologists, academic institutions, hospitals, life sciences researchers, and regulatory bodies manage patient information, share data, and run real-world data-driven studies. The product works by providing a cancer-specific EHR and real-time data integration that connects various stakeholders to enable smarter research and better patient outcomes. It differentiates itself through its narrow focus on oncology, real-world data capabilities, and collaboration across providers, researchers, and regulators, supported by a strong emphasis on data quality (e.g., recognition like the American Cancer Society Data Impact Award). The company aims to improve cancer care and accelerate research by turning real-world data into actionable insights and enabling evidence generation for new treatments.

Company Size

1,001-5,000

Company Stage

Acquired

Total Funding

$313.1M

Headquarters

New York City, New York

Founded

2012

Get referred to Flatiron Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 22, 2026 Scotland partnership widened Flatiron's ex-US network nearly 70%.
  • March 30, 2026 Abbott integrated precision oncology testing into OncoEMR.
  • Flatiron announced 49-plus ASCO 2026 acceptances, validating its AI and real-world evidence pipeline.

What critics are saying

  • Paradigm bought Flatiron's clinical research business in December 2025, stripping a core moat.
  • Headcount fell 23.6% from 2023 to March 2026, signaling organizational shrinkage.
  • Roche still owns Flatiron; another budget reset can turn it into a services appendage.

What makes Flatiron Health unique

  • Flatiron Telescope turns 15 years of oncology data into minutes-level cohort answers.
  • OncoEMR sits inside 1,600 cancer centers and 4,700 provider workflows.
  • VALID framework gives Flatiron a published standard for LLM-extracted oncology data quality.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Work/life autonomy via flexible work hours and flexible paid time off

Generous parental leave (16 weeks for either parent)

Transition back to work program following parental leave

Child and caregiver travel benefits for new parents

Backup child care

Weekly meditation sessions

Flatiron-sponsored fitness classes

Weekly massages and manicures available onsite (employee funded)

Growth & Insights and Company News

Headcount

6 month growth

-1%

1 year growth

0%

2 year growth

-1%
Express-Press-Release.net
Aug 22nd, 2026
Healthcare data technology market: Challenges in privacy and compliance.

Healthcare data technology market: Challenges in privacy and compliance. Healthcare organizations are sitting on more data than ever before - electronic health records, connected devices, claims, imaging, and real-world evidence - and the race is on to turn that raw information into something usable. That race is fueling rapid growth in the healthcare data technology market, a space built around integrating, standardizing, securing, and monetizing health data at scale. Here's a closer look at where the market stands today, what's driving it forward, and the roadblocks still standing in the way. Key Market Facts The global healthcare data technology market was valued at USD 3.1 billion in 2024 and is projected to grow from USD 4.0 billion in 2026 to USD 9.5 billion by 2033, expanding at a compound annual growth rate of 13.4% between 2025 and 2033. A few other numbers worth noting: * North America led the market in 2024, capturing a 46.5% revenue share, while Asia Pacific is on track to be the fastest-growing region going forward. * By technology, the health data integration and monetization segment dominated in 2024, holding more than 66.55% of total revenue, as providers work to unify EHRs, clinical trial data, and real-world evidence into single, usable pipelines. * The data harmonization and structuring segment, though smaller today, is expected to post the fastest growth rate of any segment over the forecast period, largely thanks to AI and NLP tools that can standardize messy, unstructured clinical data. * EHR adoption remains the backbone of this demand: as of December 2024, roughly 88% of U.S. office-based physicians were using an EMR/EHR system, with nearly 78% on a certified platform - a base that keeps generating more data to integrate and analyze. * The competitive landscape is notably fragmented, with dozens of established and emerging vendors - including IQVIA, Veeva Systems, Oracle (Cerner), Optum, Datavant, TriNetX, and Flatiron Health - all competing for share, which keeps innovation and partnership activity high. Major Industry Trends AI and advanced analytics are moving from pilot to production. Vendors are embedding generative AI and machine learning directly into data platforms rather than treating them as add-ons. Oracle's newly launched AI Data Platform, for example, is designed to help enterprises build AI-ready data lakes and deploy AI-driven applications directly on top of unified data. Global harmonization initiatives are reshaping the data landscape. Governments and health systems are investing heavily in standardizing and connecting fragmented health records. Europe's Health Data Space regulation, formally adopted in 2025, sets a legally binding framework for cross-border health data access across the EU, covering both direct patient care and secondary research use. The UK has committed roughly £600 million toward a national Health Data Research Service, while Germany has launched a similarly ambitious medical informatics funding program - all aimed at making health data more accessible for research and care. Discover more Internet & Telecom Commercial Distribution Public Relations Interoperability is becoming a regulatory mandate, not just a best practice. In the U.S., federal regulators have intensified enforcement of information-blocking rules under the 21st Century Cures Act, pushing providers and vendors to make electronic health information more freely accessible and exchangeable. Strategic partnerships and M&A are accelerating capability-building. Rather than building every capability in-house, companies are teaming up or acquiring their way into new strengths - from IQVIA and Veeva's long-term global partnership to streamline clinical trials, to Samsung's acquisition of digital health platform Xealth, to Commvault's move to acquire data security firm Satori Cyber to strengthen protections around AI training data. Social determinants of health (SDOH) and real-world data are being folded into core platforms. Partnerships like HealthEdge and Unite Us embedding SDOH data into care management platforms reflect a broader shift toward more holistic, value-based data models that go beyond clinical records alone. Emerging technologies are tackling harmonization at scale. Graph databases, federated learning frameworks, and AI-driven semantic mapping are increasingly used to link genomic, clinical, and multi-institutional datasets - enabling collaborative research without centralizing sensitive patient data. Need data specific to your market or segment? This report can be tailored with additional countries, segments, or data points to match your exact research needs - with free customization available on purchase. Request Report Customization Primary System Challenges Data fragmentation across legacy systems. Many healthcare organizations still operate with claims, patient records, and lab results scattered across disconnected legacy systems, creating operational bottlenecks and slowing down everything from claims processing to clinical research. Regulatory complexity and compliance costs. Stringent privacy and security frameworks - HIPAA, GDPR, and a growing patchwork of regional health data governance rules - demand robust compliance and audit capabilities. While these regulations push innovation in secure data management, they also add real implementation complexity and cost for both providers and vendors. Discover more Communications & Media Studies communication Interoperability gaps between platforms. Despite widespread EHR adoption, getting different systems to talk to each other in a standardized way (HL7/FHIR and beyond) remains a persistent hurdle, particularly for organizations trying to merge imaging, genomic, and unstructured clinical data. Balancing data monetization with privacy. As organizations look to unlock value from health data - through analytics, research partnerships, or licensing - they must simultaneously protect patient privacy, driving demand for de-identification, pseudonymization, and governance tools that can slow down time-to-insight. Scalability under growing data volumes. As data volume and variety expand (from wearables, genomics, and real-world evidence), organizations need cloud-native, auto-scaling infrastructure - a shift that isn't trivial for institutions still running on manual or semi-automated processes. Regional disparities in infrastructure and investment. While North America and Europe are pushing ahead with major national data initiatives, regions like Latin America and parts of MEA are still working to modernize foundational health data infrastructure, creating uneven adoption rates globally. The bigger picture: healthcare data technology is no longer a back-office IT concern - it's becoming central to how care gets delivered, how research gets funded, and how health systems compete. Organizations that solve for interoperability, compliance, and scalability today will be the ones best positioned to capture value as the market roughly triples in size by 2033. Discover more communications Business & Industrial Want the Full Picture? See who's leading the market. Get access to detailed profiles of the key players shaping the healthcare data technology space - including IQVIA, Veeva Systems, Oracle, Optum, Datavant, and more - along with their strategies, partnerships, and market positioning. Explore Key Players Explore our dedicated business services: * U.S. Healthcare Facility Mapping & Intelligence Portal - Claims analytics (MS-DRG, service lines, ICD-10 outpatient, APC reimbursement, CPT-level) plus hospital-level financials (balance sheet, income statement, uncompensated care, financial health dashboards), covering 25,000+ healthcare facilities - including 7,000+ hospitals, independent pharmacies, freestanding EDs, concierge physicians, and ASCs. * Brainshare Consulting - End-to-end business consulting services including Opportunity assessment, GTM support, Competitive intelligence, and Consumer Analytics. * Custom Research - Get a market intelligence report tailored to your specific requirements and aligned with your business goals. * Consumer Insights - Capture real, evolving consumer sentiment and behavior to help you make data driven strategies. * Horizon Databooks - Access the world's largest portal of Market Reports & Statistics * Investment Insights - Make investment decisions with data driven insights, powered by domain and technology * Signal (Pricing Intelligence) - Commodity price intelligence to drives strategic advantage. About us: Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide. Matched content.

Business Wire
May 21st, 2026
Flatiron Health presents 25+ AI-powered cancer research studies at ASCO 2026

Flatiron Health has announced 25-plus research acceptances at the American Society of Clinical Oncology Annual Meeting, taking place from 29 May to 2 June 2026 in Chicago. The presentations include 14 Flatiron-authored posters covering digital twin modelling, physician adoption of clinical trials and recurrence risk prediction. The announcement follows the launch of Flatiron Telescope, a multi-agent adaptive analytics platform designed to help life sciences teams identify patients faster and generate oncology insights on demand. The platform will be demonstrated at the company's booth. Research highlights include digital twin modelling for treatment prediction in non-small cell lung cancer, large-language model analysis of how clinical trial findings translate to practice, and real-world treatment patterns in platinum-resistant ovarian cancer. The work spans advanced AI capabilities and real-world evidence validation across multiple cancer types.

Business Wire
May 19th, 2026
Flatiron Health launches AI platform that delivers oncology insights in minutes

Flatiron Health has launched Flatiron Telescope, an AI-powered platform that enables life sciences teams and researchers to generate oncology insights in minutes using natural language queries. The platform translates complex inclusion and exclusion criteria into patient cohorts without requiring coding skills. Built on over 15 years of longitudinal data from more than 4,700 providers across 1,600 sites, Flatiron Telescope covers roughly two in five cancer patients and spans over 5 million patient journeys across the US, UK, Germany and Japan. The platform's multi-agent adaptive analytics engine allows users to dynamically stratify cohorts by biomarkers, treatment history and lines of therapy whilst generating real-time feasibility assessments. The platform aims to democratise access to oncology insights across clinical development, real-world evidence and commercial functions, reducing the time from hypothesis to insight from months to minutes.

Business Wire
Apr 20th, 2026
Flatiron Health publishes first peer-reviewed framework for validating AI-extracted cancer data

Flatiron Health has published the Validation of Accuracy for LLM/ML-Extracted Information and Data (VALID) Framework in the Journal of Clinical Oncology Clinical Cancer Informatics. The framework represents the first peer-reviewed approach to evaluating real-world oncology data extracted by large language models and machine learning. The VALID Framework employs three pillars: variable-level performance metrics benchmarking LLM extraction against human abstraction, automated verification checks identifying data inconsistencies, and replication analyses confirming LLM-extracted results match established clinical findings. Flatiron applies this framework to datasets with longitudinal records across millions of patients and over 1.5 billion data points. The framework aims to establish industry standards for AI-extracted clinical data quality whilst maintaining rigour for high-stakes cancer care and drug development decisions.

Yahoo Finance
Mar 30th, 2026
Abbott integrates precision oncology tests into OncoEMR, reaching 1,600 cancer centres

Abbott Laboratories has integrated its Precision Oncology portfolio into Flatiron Health's OncoEMR platform, giving over 1,600 community cancer centres and 4,700 providers direct access to tests including Oncotype DX and OncoExTra within their clinical workflows. The integration allows clinicians to order and receive cancer diagnostic results without leaving their electronic medical records system. This follows Abbott's recent integration of its Libre continuous glucose monitoring data into Epic's health record system, part of a broader strategy to embed its products into clinical workflows. Whilst the move may enhance test adoption and streamline administrative tasks, analysts suggest it is unlikely to significantly shift Abbott's near-term investment narrative, which remains centred on its core devices business and managing margin pressure from tariffs and foreign exchange headwinds.